Log in

334970 Prestige Biologics Co., Ltd. KRX · South Korea

Prestige Biologics Co. (334970) news

Prestige Biologics Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 334970, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Prestige Biologics Co. news

We have not published a story on Prestige Biologics Co. yet. When there is news, it will appear here.

Questions about Prestige Biologics Co.

What is the ticker symbol of Prestige Biologics Co.?

Prestige Biologics Co., Ltd. trades under the ticker 334970 on KRX.

Where is Prestige Biologics Co. listed?

Prestige Biologics Co., Ltd. is listed on KRX.

Which country or territory is Prestige Biologics Co. listed under?

Our directory records Prestige Biologics Co., Ltd. under South Korea.

What does Prestige Biologics Co. do?

Our directory classifies Prestige Biologics Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Prestige Biologics Co.?

The ISIN recorded for Prestige Biologics Co., Ltd. is KR7334970001.

Does aibio.space cover Prestige Biologics Co.?

aibio.space lists Prestige Biologics Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Prestige Biologics Co.?

Companies in our directory listed in the same country and business area as Prestige Biologics Co.: CTC Bio, EuBiologics Co., JW Holdings, ABL Bio, Korean Drug Co., Kyongbo Pharmaceutical Co..

Investor discussion: Prestige Biologics Co.

Members talk about Prestige Biologics Co. (334970). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:334970 on TradingView.

Listing details

Prestige Biologics Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 334970, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Prestige Biologics Co., Ltd.
Ticker
334970
Listing
KRX
Country or territory
South Korea
Business scope
Pharmaceuticals: Major
ISIN
KR7334970001
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.